CN116240225A - Series tobacco NtHQT gene and application thereof - Google Patents
Series tobacco NtHQT gene and application thereof Download PDFInfo
- Publication number
- CN116240225A CN116240225A CN202310039140.9A CN202310039140A CN116240225A CN 116240225 A CN116240225 A CN 116240225A CN 202310039140 A CN202310039140 A CN 202310039140A CN 116240225 A CN116240225 A CN 116240225A
- Authority
- CN
- China
- Prior art keywords
- gene
- tobacco
- genes
- nthqt2
- nthqt3
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 164
- 235000002637 Nicotiana tabacum Nutrition 0.000 title claims abstract description 87
- 241000208125 Nicotiana Species 0.000 title claims abstract description 78
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 claims abstract description 48
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 claims abstract description 47
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 claims abstract description 47
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 claims abstract description 47
- 235000001368 chlorogenic acid Nutrition 0.000 claims abstract description 47
- 229940074393 chlorogenic acid Drugs 0.000 claims abstract description 47
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 claims abstract description 47
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 claims abstract description 47
- 241000196324 Embryophyta Species 0.000 claims abstract description 42
- 230000014509 gene expression Effects 0.000 claims abstract description 32
- 230000002018 overexpression Effects 0.000 claims abstract description 17
- 238000010362 genome editing Methods 0.000 claims abstract description 15
- 238000005516 engineering process Methods 0.000 claims abstract description 7
- 238000010353 genetic engineering Methods 0.000 claims abstract description 7
- 108090000992 Transferases Proteins 0.000 claims abstract description 5
- 102000004357 Transferases Human genes 0.000 claims abstract description 5
- 238000012408 PCR amplification Methods 0.000 claims description 14
- 239000013598 vector Substances 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 13
- 230000015572 biosynthetic process Effects 0.000 claims description 12
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 claims description 12
- 239000013612 plasmid Substances 0.000 claims description 11
- 238000003786 synthesis reaction Methods 0.000 claims description 10
- 230000030279 gene silencing Effects 0.000 claims description 6
- 238000012226 gene silencing method Methods 0.000 claims description 6
- -1 hydroxycinnamoyl coenzyme A Chemical compound 0.000 claims description 3
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 claims 1
- 239000005516 coenzyme A Substances 0.000 claims 1
- 229940093530 coenzyme a Drugs 0.000 claims 1
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 claims 1
- 239000013613 expression plasmid Substances 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 238000011160 research Methods 0.000 abstract description 10
- 230000037361 pathway Effects 0.000 abstract description 6
- 230000033228 biological regulation Effects 0.000 abstract description 5
- 229930000044 secondary metabolite Natural products 0.000 abstract description 5
- UZMZQIZIJQTHDK-VXAHOBLNSA-N S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] 2-hydroxy-3-phenylprop-2-enethioate Chemical compound O=C([C@H](O)C(C)(COP(O)(=O)OP(O)(=O)OC[C@@H]1[C@H]([C@@H](O)[C@@H](O1)N1C2=NC=NC(N)=C2N=C1)OP(O)(O)=O)C)NCCC(=O)NCCSC(=O)C(O)=CC1=CC=CC=C1 UZMZQIZIJQTHDK-VXAHOBLNSA-N 0.000 abstract description 4
- 238000002474 experimental method Methods 0.000 abstract description 4
- 230000002596 correlated effect Effects 0.000 abstract description 2
- 230000009261 transgenic effect Effects 0.000 description 17
- 238000011144 upstream manufacturing Methods 0.000 description 14
- 239000000047 product Substances 0.000 description 13
- 238000001514 detection method Methods 0.000 description 12
- 239000000243 solution Substances 0.000 description 10
- 108020004414 DNA Proteins 0.000 description 9
- 244000061176 Nicotiana tabacum Species 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 239000002609 medium Substances 0.000 description 9
- 238000012163 sequencing technique Methods 0.000 description 9
- 230000012010 growth Effects 0.000 description 8
- 241000589158 Agrobacterium Species 0.000 description 7
- 230000035772 mutation Effects 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 230000008685 targeting Effects 0.000 description 6
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000002299 complementary DNA Substances 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 238000003753 real-time PCR Methods 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 150000001413 amino acids Chemical group 0.000 description 4
- 238000000137 annealing Methods 0.000 description 4
- 238000012217 deletion Methods 0.000 description 4
- 230000037430 deletion Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 238000001890 transfection Methods 0.000 description 4
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 108091033409 CRISPR Proteins 0.000 description 3
- 206010064571 Gene mutation Diseases 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000004883 caffeic acid Nutrition 0.000 description 3
- 229940074360 caffeic acid Drugs 0.000 description 3
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000012257 pre-denaturation Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108091029865 Exogenous DNA Proteins 0.000 description 2
- 238000010802 RNA extraction kit Methods 0.000 description 2
- 238000011529 RT qPCR Methods 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 108091027544 Subgenomic mRNA Proteins 0.000 description 2
- 108010006785 Taq Polymerase Proteins 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 239000012154 double-distilled water Substances 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 238000003209 gene knockout Methods 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000013600 plasmid vector Substances 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- AAWZDTNXLSGCEK-LNVDRNJUSA-N (3r,5r)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid Chemical compound O[C@@H]1CC(O)(C(O)=O)C[C@@H](O)C1O AAWZDTNXLSGCEK-LNVDRNJUSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- NGSWKAQJJWESNS-ZZXKWVIFSA-M 4-Hydroxycinnamate Natural products OC1=CC=C(\C=C\C([O-])=O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-M 0.000 description 1
- DFYRUELUNQRZTB-UHFFFAOYSA-N Acetovanillone Natural products COC1=CC(C(C)=O)=CC=C1O DFYRUELUNQRZTB-UHFFFAOYSA-N 0.000 description 1
- 108700016155 Acyl transferases Proteins 0.000 description 1
- 102000057234 Acyl transferases Human genes 0.000 description 1
- FMBALSGATPXMMT-QIUSXKNJSA-N C1[C@H](C([C@@H](CC1(C(=O)O)O)O)O)O.OC(C(=O)SCCNC(CCNC([C@@H](C(COP(OP(OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=NC=2C(N)=NC=NC12)O)OP(=O)(O)O)(=O)O)(=O)O)(C)C)O)=O)=O)=CC1=CC=CC=C1 Chemical compound C1[C@H](C([C@@H](CC1(C(=O)O)O)O)O)O.OC(C(=O)SCCNC(CCNC([C@@H](C(COP(OP(OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=NC=2C(N)=NC=NC12)O)OP(=O)(O)O)(=O)O)(=O)O)(C)C)O)=O)=O)=CC1=CC=CC=C1 FMBALSGATPXMMT-QIUSXKNJSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- AAWZDTNXLSGCEK-UHFFFAOYSA-N Cordycepinsaeure Natural products OC1CC(O)(C(O)=O)CC(O)C1O AAWZDTNXLSGCEK-UHFFFAOYSA-N 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- 108020005004 Guide RNA Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 150000004008 N-nitroso compounds Chemical class 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 235000016496 Panda oleosa Nutrition 0.000 description 1
- 240000000220 Panda oleosa Species 0.000 description 1
- 108020005120 Plant DNA Proteins 0.000 description 1
- AAWZDTNXLSGCEK-ZHQZDSKASA-N Quinic acid Natural products O[C@H]1CC(O)(C(O)=O)C[C@H](O)C1O AAWZDTNXLSGCEK-ZHQZDSKASA-N 0.000 description 1
- 108091081021 Sense strand Proteins 0.000 description 1
- 208000035199 Tetraploidy Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004103 aerobic respiration Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- QHRGJMIMHCLHRG-FUEUKBNZSA-N caffeoyl-CoA Chemical compound O=C([C@H](O)C(C)(COP(O)(=O)OP(O)(=O)OC[C@@H]1[C@H]([C@@H](O)[C@@H](O1)N1C2=NC=NC(N)=C2N=C1)OP(O)(O)=O)C)NCCC(=O)NCCSC(=O)C=CC1=CC=C(O)C(O)=C1 QHRGJMIMHCLHRG-FUEUKBNZSA-N 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000002247 constant time method Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000002222 downregulating effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000012215 gene cloning Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 108010023642 hydroxycinnamoyl-CoA-quinate transferase Proteins 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002530 phenolic antioxidant Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000012916 structural analysis Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8262—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield involving plant development
- C12N15/827—Flower development or morphology, e.g. flowering promoting factor [FPF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y203/00—Acyltransferases (2.3)
- C12Y203/01—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
- C12Y203/01099—Quinate O-hydroxycinnamoyltransferase (2.3.1.99)
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
本发明属于烟草基因工程技术领域,具体涉及系列烟草NtHQT基因及其应用。系列烟草NtHQT基因包括烟草羟基肉桂酰辅酶A奎尼羟基肉桂转移酶NtHQT2基因和NtHQT3基因两个。本申请中,在现有针对烟草NtHQT基因研究基础上,挖掘了两个新的NtHQT2、NtHQT3基因。通过利用基因编辑技术对这两个基因进行沉默和通过对这两个基因进行超表达实验,结果表明,这两个基因表达量与烟叶中绿原酸含量呈现正相关关系。基于这些结果,不仅可为烟草中次生代谢产物调节路径研究奠定一定理论基础,也可为相关植物新品种培育奠定一定技术基础。The invention belongs to the technical field of tobacco genetic engineering, and in particular relates to a series of tobacco NtHQT genes and applications thereof. The series of tobacco NtHQT genes include tobacco hydroxycinnamoyl-CoA quinyl hydroxycinnamon transferase NtHQT2 gene and NtHQT3 gene. In this application, two new NtHQT2 and NtHQT3 genes were excavated based on the existing research on tobacco NtHQT genes. By using gene editing technology to silence these two genes and through overexpression experiments on these two genes, the results show that the expression of these two genes is positively correlated with the content of chlorogenic acid in tobacco leaves. Based on these results, it can not only lay a certain theoretical foundation for the research on the regulation pathway of secondary metabolites in tobacco, but also lay a certain technical foundation for the cultivation of new varieties of related plants.
Description
技术领域technical field
本发明属于烟草基因工程技术领域,具体涉及系列烟草NtHQT基因及其应用。The invention belongs to the technical field of tobacco genetic engineering, and specifically relates to a series of tobacco NtHQT genes and applications thereof.
背景技术Background technique
绿原酸(Chlorogenic acid,CGA),又名咖啡单宁,自然合成途径中,由植物在有氧呼吸过程中经苯丙氨酸途径产生,是一种由奎尼酸和某些反式肉桂酸如咖啡酸、对香豆酸和阿魏酸形成的酯类化合物。Chlorogenic acid (CGA), also known as coffee tannin, is produced by plants through the phenylalanine pathway in the process of aerobic respiration in the natural synthesis pathway. Esters of acids such as caffeic acid, p-coumaric acid and ferulic acid.
绿原酸作为一种酚类抗氧化剂,能快速地消除羟基自由基。实际开发应用中,除了利用绿原酸的抗氧化性外,研究还发现绿原酸具有抑制和杀灭多种致病菌和病毒、抗肿瘤、抑制突变、保肝利胆、降血压、降血脂等多种功能。例如:研究发现绿原酸在体外可抑制基因突变、抑制致癌的N-亚硝基化合物的形成以及DNA损伤;能够显著抑制肿瘤细胞的增殖与浸润;在体外具有抵御多种致病细菌、抗病毒等药理学作用。绿原酸还能够降低甘油三脂和胆固醇,预防高血压、冠心病等心血管疾病,通过调节葡萄糖代谢抵御肥胖和糖尿病,其还可以抑制炎症反应和减少疼痛。研究认为,绿原酸广泛的生物学功能与其显著的抗氧化作用程正相关,有研究发现绿原酸及其衍生物清除自由基的能力明显高于经典的抗氧化剂抗坏血酸、生育酚,其能够有效的清除羟自由基和超氧阴离子自由基。绿原酸在体内可以被小肠直接吸收,或是经过大肠菌群水解后变成咖啡酸,咖啡酸和绿原酸一样也都具有较强的抗氧化能力。As a phenolic antioxidant, chlorogenic acid can quickly eliminate hydroxyl radicals. In actual development and application, in addition to utilizing the antioxidant properties of chlorogenic acid, studies have also found that chlorogenic acid can inhibit and kill a variety of pathogenic bacteria and viruses, anti-tumor, inhibit mutation, protect liver and gallbladder, lower blood pressure, lower Blood lipids and many other functions. For example: studies have found that chlorogenic acid can inhibit gene mutations, the formation of carcinogenic N-nitroso compounds and DNA damage in vitro; it can significantly inhibit the proliferation and infiltration of tumor cells; Pharmacological effects such as viruses. Chlorogenic acid can also reduce triglycerides and cholesterol, prevent cardiovascular diseases such as hypertension and coronary heart disease, and resist obesity and diabetes by regulating glucose metabolism. It can also inhibit inflammation and reduce pain. Studies have shown that the wide range of biological functions of chlorogenic acid is positively related to its significant antioxidant activity. Some studies have found that the ability of chlorogenic acid and its derivatives to scavenge free radicals is significantly higher than that of classic antioxidants ascorbic acid and tocopherol. Effectively scavenge hydroxyl radicals and superoxide anion radicals. Chlorogenic acid can be directly absorbed by the small intestine in the body, or it can be converted into caffeic acid after being hydrolyzed by coliform bacteria. Caffeic acid, like chlorogenic acid, also has strong antioxidant capacity.
作为一种次生代谢产物,绿原酸在多种植物中均有表达和分布。测定和调查表明,烟叶中绿原酸含量为3%-5%,是含量较好植物物种之一。而且绿原酸是烟叶中含量最高的多酚类化合物,约占总的多酚含量的70-90% 。因此,研究清楚烟叶中绿原酸合成调节途径,对于烟叶品种培育以及烟草资源开发具有重要的技术意义。As a secondary metabolite, chlorogenic acid is expressed and distributed in a variety of plants. Measurements and surveys show that the content of chlorogenic acid in tobacco leaves is 3%-5%, which is one of the plant species with better content. Moreover, chlorogenic acid is the polyphenol compound with the highest content in tobacco leaves, accounting for about 70-90% of the total polyphenol content. Therefore, it is of great technical significance to study the regulation pathway of chlorogenic acid synthesis in tobacco leaves for the cultivation of tobacco leaf varieties and the development of tobacco resources.
相关合成机理研究表明,羟基肉桂酰辅酶A奎尼羟基肉桂转移酶(hydroxycinnamoyl-CoA quinate hydroxycinnamoyl transferase, HQT)是植物绿原酸合成代谢途径中的关键酶,可催化咖啡酰-CoA和奎尼酸生成绿原酸。利用基因工程技术,在部分植物中,通过超表达或者对基因进行沉默,可对应的提高或者降低植物中绿原酸含量。但HQT作为BAHD(酰基-辅酶A-依赖的酰基转移酶)家族一员,本身基因结构即较为复杂,且包含了多个基因类型,因此,深入研究不同HQT基因结构差异,对于绿原酸合成途径的深入研究、以及相关植物品种培育是具有重要的技术意义的。Studies on the relevant synthesis mechanism have shown that hydroxycinnamoyl-CoA quinate hydroxycinnamoyl transferase (HQT) is a key enzyme in the synthetic and metabolic pathway of plant chlorogenic acid, which can catalyze caffeoyl-CoA and quinic acid Produces chlorogenic acid. Using genetic engineering technology, in some plants, through overexpression or gene silencing, the content of chlorogenic acid in plants can be increased or decreased accordingly. However, as a member of the BAHD (acyl-CoA-dependent acyltransferase) family, HQT itself has a relatively complex gene structure and includes multiple gene types. The in-depth study of pathways and the cultivation of related plant varieties are of great technical significance.
发明内容Contents of the invention
在申请人已有的关于烟草NtHQT基因研究工作基础上,本申请目的在于提供两个新的烟草羟基肉桂酰辅酶A奎尼羟基肉桂转移酶NtHQT基因(NtHQT2、NtHQT3),从而为烟草(烟叶)中次生代谢产物调节机理、以及烟草新品种培育奠定一定技术基础。On the basis of the applicant's existing research work on tobacco NtHQT genes, the purpose of this application is to provide two new tobacco hydroxycinnamoyl-CoA quinyl hydroxycinnamon transferase NtHQT genes (NtHQT2, NtHQT3), so as to provide tobacco (tobacco) The regulation mechanism of secondary metabolites and the cultivation of new tobacco varieties have laid a certain technical foundation.
本申请所采取的技术方案详述如下。The technical solution adopted by this application is described in detail as follows.
系列烟草NtHQT基因,包括烟草羟基肉桂酰辅酶A奎尼羟基肉桂转移酶NtHQT2基因和NtHQT3基因两个;A series of tobacco NtHQT genes, including tobacco hydroxycinnamoyl-CoA quinyl hydroxycinnamon transferase NtHQT2 gene and NtHQT3 gene;
所述NtHQT2基因,与烟草(烟叶)中绿原酸合成相关(或者说与烟叶中绿原酸含量调节相关),其克隆获得自普通烟草K326,碱基序列如SEQ ID No.1所示;具体如下:The NtHQT2 gene is related to the synthesis of chlorogenic acid in tobacco (tobacco leaves) (or related to the regulation of chlorogenic acid content in tobacco leaves), and its clone is obtained from common tobacco K326, and its base sequence is shown in SEQ ID No.1; details as follows:
NtHQT2基因序列(1311bp)NtHQT2 gene sequence (1311bp)
ATGGGAAGTGAAAAGATGATGAAGATTAACATCAAAGAATCAACATTAGTAAAACCATCAAAACCAACACCAACAAAGAGACTTTGGAATTCTAACTTAGATTTAATAGTTGGAAGAATTCATCTTTTAACAGTATATTTCTATAAACCAAATGGATCTTCAAATTTCTTTGATTCTAAAGTAATGAAAGAAGCATTAAGTAATGTTCTTGTTTCATTTTATCCAATGGCTGGGAGATTAGCTAGAGATGAACAAGGAAGAATTGAGATAAATTGTAATGGAGAAGGAGTTTTGTTTGTTGAAGCTGAAAGTGATGCTTTTGTTGATGATTTTGGTGATTTTACTCCAAGTTTGGAACTTAGGAAACTTATTCCTACTGTTGATACTTCTGGTGATATTTCTACTTTCCCCCTCATCATCTTTCAGGTTACTCGTTTCAAATGTGGTGGAGTTTCACTTGGTGGAGGAGTATTCCACACTCTATCAGATGGTCTCTCATCCATTCACTTCATCAACACATGGTCCGATATTGCCCGAGGCCTCTCCGTCGTCATCCCGCCGTTCATTGACCGGACCCTCCTCCGTGCACGGGACCCACCGACATCGTCGTTCGAACACGTCGAGTATCATCCTCCTCCATCTCTTATTTCATCATCAAAAACCAAAGAATCCACTAGCCCAAAGCCTAGTACCACAACCATGTTAAAATTCTCTAGTGACCAACTTGGGCTTCTAAAGTCCAAGTCCAAACATGATGGTAGCACTTACGAAATCCTCGCGGCCCATATTTGGCGTTGCACGTGCAAGGCACGTGCACTGTCCGACGATCAATTGACCAAATTACATGTGGCCACTGATGGTAGGTCTAGGCTTTGCCCTCCTTTGCCACCAGGTTACTTAGGAAATGTTGTGTTCACAGGCACACCTATGGCAAAATCAAGTGAACTTTTACAAGAACCATTGACAAATTCAGCCAAGAGAATTCATAGTGCATTATCAAAAATGGATGACAATTACCTAAGATCAGCTCTCGATTACCTCGAATTACTGCCCGATTTATCGGCTTTAATCCGTGGACCGACGTACTTTGCTAGCCCTAATCTTAATATTAATAGTTGGACTAGATTGCCTGTTCATGATTCAGATTTTGGATGGGGAAGGCCAATTCATATGGGACCAGCTTGCATTTTATATGAAGGGACAGTTTATATATTGCCAAGTCCAAATAGTAAAGATAGGAACTTGCGTTTGGCTGTTTGTTTAGATGCTGATCACATGCCACTATTTGAGAAGTATTTGTATGAATTTTGA;ATGGGAAGTGAAAAGATGATGAAGATTAACATCAAAGAATCAACATTAGTAAAACCATCAAAACCAACACCAACAAAGAGACTTTGGAATTCTAACTTAGATTTAATAGTTGGAAGAATTCATCTTTTAACAGTATATTCTATAAACCAAATGGATCTTCAAATTTCTTTGATTCTAAAGTAATGAAAGAAGCATTAAGTAATGTTCTTGTTTCATTTTATCCAATG GCTGGGAGATTTAGCTAGAGATGAACAAGGAAGAATTGAGATAAATTGTAATGGAGAAGGAGTTTTGTTTGTTGAAGCTGAAAGTGATGCTTTTGTTGATGATTTTGGTGATTTTACTCCAAGTTTGGAACTTAGGAAACTTATTCCTACTGTTGATACTTCTGGTGATATTTCTACTTCCCCCTCATCTTTCAGGTTACTCGTTTCAAATGTGGTGGAGT TTCACTTGGTGGAGGAGTATTCCACACTCTATCAGATGGTCTCTCATCCATTCACTTCATCAACACATGGTCCGATATTGCCCGAGGCCTCTCCGTCGTCATCCCGCCGTTCATTGACCGGACCCCTCCTCCGTGCACGGGACCCACCGACATCGTCGTTCGAACACGTCGAGTATCATCCTCCTCCATCTCTTATTTCATCATCAAAAACCAAAGAATCCACTAGCCC AAAGCCTAGTACCACAACCATGTTAAAATTCTCTAGTGACCAACTTGGGCTTCTAAAGTCCAAGTCCAAACATGATGGTAGCACTTACGAAATCCTCGCGGCCCATATTTGGCGTTGCACGTGCAAGGCACGTGCACTGTCCGACGATCAATTGACCAAATTACATGTGGCCACTGATGGTAGGTCTAGGCTTTGCCCTCCTTTGCCACCAGGTTACTTAGGAA ATGTTGTGTTCACAGGCACACCTATGGCAAAATCAAGTGAACTTTTACAAAGAACCATTGACAAATTCAGCCAAGAGAATTCATAGTGCATTATCAAAAATGGATGACAATTACCTAAGATCAGCTCTCGATTACCTCGAATTACTGCCCGATTTATCGGCTTTAATCCGTGGACCGACGTACTTTGCTAGCCCTAATCTTAATATTAATAGTTGGACTAGATTGCCTGTTCATGA TTCAGATTTTGGATGGGGAAGGCCAATTCATATGGGACCAGCTTGCATTTTATATGAAGGGACAGTTTATATTGCCAAGTCCAAATAGTAAAGATAGGAACTTGCGTTTGGCTGTTTGTTTAGATGCTGATCACATGCCACTATTTGAGAAGTATTTGTATGAATTTTGA;
对应的,所述NtHQT2基因所编码的NtHQT2蛋白,氨基酸序列(436AA)如下:Correspondingly, the amino acid sequence (436AA) of the NtHQT2 protein encoded by the NtHQT2 gene is as follows:
MGSEKMMKINIKESTLVKPSKPTPTKRLWNSNLDLIVGRIHLLTVYFYKPNGSSNFFDSKVMKEALSNVLVSFYPMAGRLARDEQGRIEINCNGEGVLFVEAESDAFVDDFGDFTPSLELRKLIPTVDTSGDISTFPLIIFQVTRFKCGGVSLGGGVFHTLSDGLSSIHFINTWSDIARGLSVVIPPFIDRTLLRARDPPTSSFEHVEYHPPPSLISSSKTKESTSPKPSTTTMLKFSSDQLGLLKSKSKHDGSTYEILAAHIWRCTCKARALSDDQLTKLHVATDGRSRLCPPLPPGYLGNVVFTGTPMAKSSELLQEPLTNSAKRIHSALSKMDDNYLRSALDYLELLPDLSALIRGPTYFASPNLNINSWTRLPVHDSDFGWGRPIHMGPACILYEGTVYILPSPNSKDRNLRLAVCLDADHMPLFEKYLYEF;MGSEKMMKINIKESTLVKPSKPTPTKRLWNSNLDLIVGRIHLLTVYFYKPNGSNFFDSKVMKEALSNVLVSFYPMAGRLARDEQGRIEINCNGEGVLFVEAESDAFVDDFGDFPSLERKLIPTVDTSGDISTFPLIIFQVTRFKCGGVSLGGGVFHTLSDGLSSIHFINTWSDIARGLSV VIPPFIDRTLLRARDPDPTSSFEHVEYHPPPSLISSSKTKESTSPKPSTTTMMLKFSSDQLGLLKSKSKHDGSTYEILAAHIWRCTCKARALSDDQLTKLHVATDGRRLLCPPLPPGYLGNVVFTGTPMAKSSELLQEPLTNSAKRIHSALSKMDDNYLRSALDYLELLPDLSALIRGPTYFASPNLNINSWTRLPVHDSDFGW GRPIHMGPACILYEGTVYILPSPNSKDRNLRLAVCLDADHMPLFEKYLYEF;
所述NtHQT3基因,为NtHQT2基因的同源基因,与烟草(烟叶)中绿原酸合成相关(或者说与烟叶中绿原酸含量调节相关),其克隆获得自普通烟草K326,碱基序列如SEQ IDNo.2所示;具体如下(1311bp):The NtHQT3 gene is a homologous gene of the NtHQT2 gene, which is related to the synthesis of chlorogenic acid in tobacco (tobacco leaves) (or related to the regulation of chlorogenic acid content in tobacco leaves), and its clone is obtained from common tobacco K326. The base sequence is as follows: Shown in SEQ ID No.2; details are as follows (1311bp):
ATGAAGATCGACATTAAGGAATCTATAATGGTGAAACCATCAAAGCCAACTCCTTCAAAAAGGCTATGGAACTCAAATTTGGATTTAATAGTGGGAAGAATTCATCTTTTGACAGTATATTTCTACAAACCAAATGGAATTTCTCCAAATTTCTTTGATTTTAGAATTATGAAGGAGGCTTTAAGCAATATTTTAGTTTCATTTTATCCAATGGCTGGGAGATTGGCTAAGGATAATAATGAAAAAGGAAGAATTGAGATAAATTGTAATGGAGAAGGGGTTCTTTTTATTGAAGCTGAAATTGATGAATTTATTGATGATTTTGGTGATGATTTTACTCCAAGTTTGGAAATAAAGAAGATGTTAATTCCTAATGTTGATACTTCTGGTGACATCTCTTCTTTTCCACTTGTCATATTTCAGGTAACTCGTTTCAAGTGTGGTGGAGTCTCTTTAGGGTGTGGCGTTTTCCATACATTATCTGACGGCATTTCATCCCTTCATTTCATCAACACATGGTCGGAAGTTGCTCGAGGCCTCTCCGTCGCCGTCTCGCCGTTCATCGACCGGTCCCTCCTTCGTGCACGGGACCCACCAACCCCCGCTTATAAACACGTCGAGTATCACCCCCCTCCGACCCTAAAATCATCGTCAGAATACGTTCATGATCAAGTTAACGGTCCAAAATCCAGCATCACGGCCATGTTTAAGATCACAAGTGACCAGCTAACCCTACTCAAGACCAAGTCAAAAAAAGAGGGTAGTACTTATGAAGTACTCGCAGCCCATATTTGGCGTTGCACGTGCAAAGCACGTGCCCTAGACAATGACCAATTGACAAAGTTACATGTTGCTACAGATGGTAGGTCAAGACTTTTTCCTCCTTTACCACCAGGTTACCTAGGAAATGTTGTTTTCACAGCTACACCAATTGCCAAATCTGGTGAAATTTTATCAGAGCCATTGATGAACACAGCTCAAAGAATTCATAGCGCGTTAGCAAGAATGGACGACGAATACTTAAGATCAGCGATAGATTATCTCGAATTACAGACAGATTTATCTAAATTAATCCGAGGACCGACGTATTTTGCTAGTCCTAATCTTAATATTAACAGTTGGACTAGGTTGCCTGTTCATGATTCAGATTTTGGATGGGGAAAACCAATTCATATGGGACCTGCATGTATTTTGTATGAAGGGACAGTTTATATATTGCCAAGTCCAAGCAATGACAAGAATTTGAGGTTGGCTGTGTGTTTAGATGCTGATCATATGCCACTTTTTGAGAAGTACCTGTATGACTTTTGA;ATGAAGATCGACATTAAGGAATCTATAATGGTGAAACCATCAAAGCCAACTCCTTCAAAAAGGCTATGGAACTCAAATTTGGATTTAATAGTGGGAAGAATTCATCTTTTGACAGTATATTTCTACAAAACCAAATGGAATTTCTCCAAATTTCTTTGATTTTAGAATTATGAAGGAGGCTTTAAGCAATATTTTAGTTTCATTTTATCCAATGGCTGGGAGATT GGCTAAGGATAATAATGAAAAAGGAAGAATTGAGATAAATTGTAATGGAGAAGGGGTTCTTTTTATTGAAGCTGAAATTGATGAATTTATTGATGATTTTGGTGATGATTTTACTCCAAGTTTGGAAATAAAGAAGATGTTTAATTCCTAATGTTGTGATCATCTTCTTTTCCACTTGTCATATTTCAGGTAACTCGTTTCAAGTGTGGTGGA GTCTCTTTAGGGTGTGGCGTTTTCCATACATTATCTGACGGCATTTCATCCCTTCATTTCATCAACACATGGTCGGAAGTTGCTCGAGGCCTCTCCGTCGCCGTCTCGCCGTTCATCGACCGGTCCCTCCTTCGTGCACGGGACCCCACCAACCCCCGCTTATAAACACGTCGAGTATCACCCCCCTCCGACCCTAAAATCATCGTCAGAATACGTTCATGATCAA GTTAACGGTCCAAAATCCAGCATCACGGCCATGTTTAAAGATCACAAGTGACCAGCTAACCCTACTCAAGACCAAGTCAAAAAAAGAGGGTAGTACTTATGAAGTACTCGCAGCCCATATTTGGCGTTGCACGTGCAAAGCACGTGCCCTAGACAATGACCAATTGACAAAGTTACATGTTGCTACAGATGGTAGGTCAAAGACTTTTTTCCTCCTTTACCACCAGGTTACC TAGGAAATGTTGTTTTTCACAGCTACACCAATTGCCAAATCTGGTGAAATTTTATCAGAGCCATTGATGAACACAGCTCAAAGAATTCATAGCGCGTTAGCAAGAATGGACGACGAATACTTAAGATCAGCGATAGATTATCTCGAATTACAGACAGATTTATCTAAATTAATCCGAGGACCGACGTATTTTGCTAGTCCTAATCTTAATATTAACAGTTGGACTAGGT TGCCTGTTCATGATTCAGATTTTGGATGGGGAAAACCAATTCATATGGGACCTGCATGTATTTTGTATGAAGGGACAGTTTATATTGCCAAGTCCAAGCAATGACAAGAATTTGAGGTTGGCTGTGTGTTTAGATGCTGATCATATGCCACTTTTTGAGAAGTACCTGTATGACTTTTGA;
对应的,所述NtHQT3基因所编码的NtHQT3蛋白,氨基酸序列(436AA)如下:Correspondingly, the amino acid sequence (436AA) of the NtHQT3 protein encoded by the NtHQT3 gene is as follows:
MKIDIKESIMVKPSKPTPSKRLWNSNLDLIVGRIHLLTVYFYKPNGISPNFFDFRIMKEALSNILVSFYPMAGRLAKDNNEKGRIEINCNGEGVLFIEAEIDEFIDDFGDDFTPSLEIKKMLIPNVDTSGDISSFPLVIFQVTRFKCGGVSLGCGVFHTLSDGISSLHFINTWSEVARGLSVAVSPFIDRSLLRARDPPTPAYKHVEYHPPPTLKSSSEYVHDQVNGPKSSITAMFKITSDQLTLLKTKSKKEGSTYEVLAAHIWRCTCKARALDNDQLTKLHVATDGRSRLFPPLPPGYLGNVVFTATPIAKSGEILSEPLMNTAQRIHSALARMDDEYLRSAIDYLELQTDLSKLIRGPTYFASPNLNINSWTRLPVHDSDFGWGKPIHMGPACILYEGTVYILPSPSNDKNLRLAVCLDADHMPLFEKYLYDF;MKIDIKESIMVKPSKPTPSKRLWNSNLDLIVGRIHLLTVYFYKPNGISPNFFDFRIMKEALSNILVSFYPMAGRLAKDNNEKGRIEINCNGEGVLFIEAEIDEFIDDFGDDFTPSLEIKKMLIPNVDTSGDISSFPLVIFQVTRFKCGGVSLGCGVFHTLSDGISSLHFINTWSEVARGLSVAVSPFID RSLLRARDPPTPAYKHVEYHPPPTLKSSSEYVHDQVNGPKSSITAMFKITSDQLTLLKTKSKKEGSTYEVLAAHIWRCTCKARALDNDQLTKLHVATDGRRLFPPLPPGYLGNVVFTATPIAKSGEILSEPLMNTAQRIHSALARMDDEYLRSAIDYLELQTDLSKLIRGPTYFASPPNLNINSWTRLPVHD SDFGWGKPIHMGPACILYEGTVYILPSPSNDKNLRLAVCLDADHMPLFEKYLYDF;
具体应用时,过表达NtHQT2基因或NtHQT3基因后,能显著提高(上调)烟叶中绿原酸的含量;在通过基因编辑或基因沉默等技术下调NtHQT2基因或NtHQT3基因表达量后,能显著降低(下调)烟叶中绿原酸的含量;In specific applications, after overexpressing the NtHQT2 gene or NtHQT3 gene, it can significantly increase (upregulate) the content of chlorogenic acid in tobacco leaves; after down-regulating the expression of NtHQT2 gene or NtHQT3 gene through gene editing or gene silencing, it can significantly reduce ( Down-regulated) the content of chlorogenic acid in tobacco leaves;
同时,过表达(超表达)NtHQT2基因或NtHQT3基因后,可以明显增加株高、促进提前开花、增加中部叶位叶片面积;At the same time, overexpression (overexpression) of NtHQT2 gene or NtHQT3 gene can significantly increase the plant height, promote early flowering, and increase the leaf area of the middle leaf;
利用所述系列烟草NtHQT基因的植物新品种培育方法,利用基因工程技术,在新品种中超表达NtHQT2基因(或NtHQT3基因)、或者低表达 NtHQT2基因(或NtHQT3基因)以获得绿原酸含量高表达或者低表达的植物新品种;Using the method for cultivating new plant varieties of the series of tobacco NtHQT genes, using genetic engineering technology, overexpressing the NtHQT2 gene (or NtHQT3 gene) or underexpressing the NtHQT2 gene (or NtHQT3 gene) in the new variety to obtain high expression of chlorogenic acid content Or new plant varieties with low expression;
其中表达NtHQT2基因(或NtHQT3基因),可以获得株高增加、开花提前、中部叶位叶片面积增加的烟草新品种。By expressing the NtHQT2 gene (or NtHQT3 gene), a new tobacco variety with increased plant height, early flowering, and increased leaf area at the middle leaf position can be obtained.
本申请中,在现有针对烟草NtHQT基因研究基础上,挖掘了两个新的NtHQT2、NtHQT3基因。通过利用基因编辑技术对这两个基因进行沉默和通过对这两个基因进行超表达实验,结果表明,这两个基因表达量与烟叶中绿原酸含量呈现正相关关系。同时,相关生长表型统计结果表明,在对这两个基因超表达时,可明显增加株高、增加中部叶位叶片面积、促进提前开花。基于这些结果,不仅可为烟草中次生代谢产物调节路径研究奠定一定理论基础,也可为相关植物新品种培育奠定一定技术基础。In this application, on the basis of existing studies on tobacco NtHQT genes, two new NtHQT2 and NtHQT3 genes were excavated. By using gene editing technology to silence these two genes and through overexpression experiments on these two genes, the results show that the expression of these two genes is positively correlated with the content of chlorogenic acid in tobacco leaves. At the same time, the statistical results of related growth phenotypes showed that when these two genes were overexpressed, the plant height could be significantly increased, the leaf area of the middle leaf position could be increased, and early flowering could be promoted. Based on these results, it can not only lay a certain theoretical foundation for the research on the regulation pathway of secondary metabolites in tobacco, but also lay a certain technical foundation for the cultivation of new varieties of related plants.
附图说明Description of drawings
图1为NtHQT2基因在不同组织中的表达特征;Figure 1 is the expression characteristics of NtHQT2 gene in different tissues;
图2为NtHQT3基因在不同组织中的表达特征;Figure 2 is the expression characteristics of NtHQT3 gene in different tissues;
图3为NtHQT2基因敲除的靶位点示意图(20 bp靶位点后面为PAM区域,+显示是正义链,星号显示指SgRNA的相对位置);Figure 3 is a schematic diagram of the target site of NtHQT2 gene knockout (the 20 bp target site is followed by the PAM region, + indicates the positive-sense strand, and the asterisk indicates the relative position of the sgRNA);
图4为NtHQT3基因敲除的靶位点示意图(20 bp靶位点后面为PAM区域,+显示是正义链,星号显示指SgRNA的相对位置);Figure 4 is a schematic diagram of the target site of NtHQT3 gene knockout (the 20 bp target site is followed by the PAM region, + indicates the sense strand, and the asterisk indicates the relative position of the sgRNA);
图5为针对NtHQT2基因的T0代转基因株系敲除靶位点测序结果;Figure 5 shows the sequencing results of the knockout target site for the T0 transgenic line of the NtHQT2 gene;
图6为针对NtHQT3基因T0代转基因株系敲除靶位点测序结果;Fig. 6 is the sequencing result of knockout target site for NtHQT3 gene T0 generation transgenic line;
图7为针对NtHQT2基因的T2代超表达和基因编辑NtHQT2基因表型图;Figure 7 is a T2 generation overexpression and gene editing NtHQT2 gene phenotype diagram for the NtHQT2 gene;
图8为针对NtHQT3基因的T2代超表达和基因编辑NtHQT3基因表型图;Figure 8 is a T2 generation overexpression and gene editing NtHQT3 gene phenotype diagram for the NtHQT3 gene;
图9为NtHQT2超表达植株NtHQT2基因表达检测;Figure 9 is the NtHQT2 gene expression detection of NtHQT2 overexpression plants;
图10为针对NtHQT2基因的T2代超表达和基因编辑转基因株系叶片中绿原酸含量测定;Figure 10 is the determination of chlorogenic acid content in the leaves of T2 generation overexpression and gene editing transgenic lines for NtHQT2 gene;
图11为超表达植株NtHQT3基因表达检测;Figure 11 is the detection of NtHQT3 gene expression in overexpressed plants;
图12为针对NtHQT3基因的T2代超表达和基因编辑转基因株系叶片中绿原酸含量测定。Fig. 12 is the measurement of chlorogenic acid content in leaves of T2 generation overexpression and gene editing transgenic lines targeting NtHQT3 gene.
具体实施方式Detailed ways
下面结合实施例对本申请做进一步的解释说明。在介绍具体实施例前,就下述实施例中部分实验背景情况简要介绍说明如下。The present application will be further explained below in conjunction with the embodiments. Before introducing specific embodiments, a brief introduction to some experimental backgrounds in the following embodiments is as follows.
生物材料:biomaterials:
烟草K326,烟草栽培和研究中常用、常见的4倍体烟草品种;申请人作为专业性烟草研究机构,长期栽培和保存有该材料;该生物材料也可由公共渠道获得;Tobacco K326, a tetraploid tobacco variety commonly used in tobacco cultivation and research; the applicant, as a professional tobacco research institution, has cultivated and preserved this material for a long time; this biological material can also be obtained from public channels;
Super pCAMBIA1300质粒,为分子生物学实验研究中常用和常见质粒载体,可由公开渠道获得;Super pCAMBIA1300 plasmid, which is a commonly used and common plasmid vector in molecular biology experimental research, can be obtained from public channels;
CRISPER/Cas9质粒,现有分子生物学研究实验中常见和常用的基因编辑用质粒载体,可由公开渠道获得,实施例中所采用质粒(pORE-Cas9/gRNA)由西南大学家蚕基因组生物学国家重点实验室惠赠提供;CRISPER/Cas9 plasmid, a common and commonly used plasmid vector for gene editing in existing molecular biology research experiments, can be obtained from public sources. Provided by the laboratory as a gift;
DH5α感受态细胞,购自上海生工生物工程技术服务有限公司;DH5α competent cells were purchased from Shanghai Sangon Bioengineering Technology Service Co., Ltd.;
LBA4404农杆菌菌株,基因工程技术中常用和常见菌株,可由公开渠道获得;LBA4404 Agrobacterium strain, commonly used and common strains in genetic engineering technology, can be obtained from public channels;
相关引物序列合成和测序工作,由北京六合华大生物工程有限公司提供完成;The synthesis and sequencing of relevant primer sequences were provided by Beijing Liuhe Huada Bioengineering Co., Ltd.;
其他实验试剂及主要设备:Other experimental reagents and main equipment:
DNA/RNA提取试剂盒,Gene Answer公司产品;DNA/RNA extraction kit, product of Gene Answer;
胶回收试剂盒/反转录试剂盒,宝生物工程(大连)有限公司产品;Gel Recovery Kit/Reverse Transcription Kit, product of Bao Bioengineering (Dalian) Co., Ltd.;
凝胶电泳仪(Bio-Rad)、PCR仪(Biometra)、UVP凝胶成像系统(GelDoc-It310)等,均为现有分子生物学实验中常见和常用仪器设备,不再赘述。Gel electrophoresis instrument (Bio-Rad), PCR instrument (Biometra), UVP gel imaging system (GelDoc-It310), etc. are common and commonly used instruments and equipment in existing molecular biology experiments, and will not be repeated here.
实施例1Example 1
前期针对烟草NtHQT基因研究工作基础上,结合现有烟草基因组工作,发明人推测认为烟草中存在类似的HQT同源基因(家族基因),为进一步摸清烟草中HQT相关的同源基因(家族基因)情况,发明人进行了进一步的基因克隆,相关工作简介如下。On the basis of the previous research work on tobacco NtHQT genes, combined with the existing tobacco genome work, the inventor speculated that there are similar HQT homologous genes (family genes) in tobacco, in order to further understand the homologous genes (family genes) related to HQT in tobacco ) situation, the inventor carried out further gene cloning, and the related work is briefly introduced as follows.
首先,基于现有烟草基因组数据和已有烟草NtHQT基因研究,发明人设计了PCR扩增用引物序列如下:First, based on the existing tobacco genome data and existing tobacco NtHQT gene research, the inventors designed the primer sequences for PCR amplification as follows:
NtHQT2-F:5 '-ATGGGAAGTGAAAAGATGAT-3 ',NtHQT2-F: 5'-ATGGGAAGTGAAAAGATGAT-3',
NtHQT2-R:5 '-TCAAAATTCATACAAATACTT-3 ';NtHQT2-R: 5'-TCAAAATTCATACAAATACTT-3';
NtHQT3-F:5 '-ATGAAGATCGACATTAAGG-3 ',NtHQT3-F: 5'-ATGAAGATCGACATTAAGG-3',
NtHQT3-R:5 '-TCAAAAGTCATACAGGTACT-3 '。NtHQT3-R: 5'-TCAAAAGTCATACAGGTACT-3'.
随后,以烟草不同生长发育时期的叶片作为样品,提取RNA(参考Gene Answer RNA提取试剂盒说明书进行提取),并参考反转录试剂盒(Takara)说明书,将所提取RNA反转录为cDNA。Subsequently, the leaves of tobacco at different growth and development stages were used as samples to extract RNA (refer to the instructions of the Gene Answer RNA extraction kit for extraction), and refer to the instructions of the reverse transcription kit (Takara) to reverse transcribe the extracted RNA into cDNA.
再后,以上述所制备cDNA为模板,分别利用前述NtHQT2-F/R、NtHQT3-F/R引物对进行PCR扩增;Then, using the cDNA prepared above as a template, PCR amplification was performed using the aforementioned NtHQT2-F/R and NtHQT3-F/R primer pairs respectively;
PCR扩增时,25 μL反应体系设计如下:During PCR amplification, the 25 μL reaction system was designed as follows:
cDNA 模板,2 μL;cDNA template, 2 μL;
上游引物,0.4 μL;Upstream primer, 0.4 μL;
下游引物,0.4 μL;Downstream primer, 0.4 μL;
PremixTaq,12.5 μL;PremixTaq, 12.5 μL;
ddH2O,9.7 μL; ddH2O , 9.7 μL;
反应程序:94 ℃预变性5 min;94 ℃变性30 s,60 ℃退火30 s,72 ℃延伸60~90s,30个循环;72 ℃延伸10 min,扩增产物直接进行后续电泳检测或者4 ℃保温备用。Reaction program: pre-denaturation at 94 °C for 5 min; denaturation at 94 °C for 30 s, annealing at 60 °C for 30 s, extension at 72 °C for 60-90 s, 30 cycles; extension at 72 °C for 10 min, the amplified product was directly detected by subsequent electrophoresis or 4 °C Keep warm.
再后,对PCR扩增产物进行1.0%琼脂糖凝胶电泳检测(DNA Maker选用DL2000,电泳条件120V/20 min),并在紫外扫描仪下观察,针对目的DNA片段用DNA胶回收试剂盒(Takara)回收并测定浓度后-20℃保存备用或直接进行后续实验操作。Then, the PCR amplification products were detected by 1.0% agarose gel electrophoresis (DNA Maker selected DL2000, the electrophoresis condition was 120V/20 min), and observed under the ultraviolet scanner, and the DNA gel recovery kit was used for the target DNA fragment ( Takara) recovered and measured the concentration and stored at -20°C for later use or directly for subsequent experimental operations.
最后,将所回收的纯化后目的片段与pMD19-T载体连接后,转化感受态细胞DH5α,筛选、摇床扩菌和鉴定后,挑选含有目的片段的重组质粒送由北京六合华大生物科技有限公司对目的基因进行测序。Finally, after linking the recovered and purified target fragment with the pMD19-T vector, the competent cell DH5α was transformed. After screening, shaking table expansion and identification, the recombinant plasmid containing the target fragment was selected and sent to Beijing Liuhe Huada Biotechnology Co., Ltd. The company sequences the gene of interest.
测序结果表明,PCR扩增所得烟草羟基肉桂酰辅酶A奎尼羟基肉桂转移酶NtHQT2基因包括1311个碱基,编码长度为436个氨基酸的蛋白质,具体核苷酸序列如SEQ ID No.1所示,NtHQT3基因作为NtHQT2基因的同源基因,其包括1311个碱基,编码长度为436个氨基酸的蛋白质,具体核苷酸序列如SEQ ID No.2所示。Sequencing results showed that the tobacco hydroxycinnamoyl-CoA quiny hydroxycinnamon transferase NtHQT2 gene amplified by PCR included 1311 bases and encoded a protein with a length of 436 amino acids. The specific nucleotide sequence is shown in SEQ ID No.1 , the NtHQT3 gene is a homologous gene of the NtHQT2 gene, which includes 1311 bases and encodes a protein with a length of 436 amino acids. The specific nucleotide sequence is shown in SEQ ID No.2.
基于上述测序结果,与现有NtHQT序列比对后,结合相关结构分析,可以认定本实施例所获得的NtHQT2基因、NtHQT3基因属于HQT家族两个新的基因。Based on the above sequencing results, after comparison with the existing NtHQT sequence, combined with related structural analysis, it can be determined that the NtHQT2 gene and NtHQT3 gene obtained in this example belong to two new genes of the HQT family.
实施例2Example 2
在实施例1基础上,借助于实时荧光定量PCR(BIO-RAD, USA)仪,发明人对本申请所涉及的NtHQT2基因、NtHQT3基因的组织表达模式进行了初步分析,从而为解读这两个基因发挥作用的组织结构部位奠定一定基础,相关试验过程简介如下。On the basis of Example 1, with the help of a real-time fluorescent quantitative PCR (BIO-RAD, USA) instrument, the inventors conducted a preliminary analysis of the tissue expression patterns of the NtHQT2 gene and NtHQT3 gene involved in this application, so as to provide a basis for interpreting these two genes To lay a certain foundation for the parts of the organizational structure that play a role, the relevant test process is briefly introduced as follows.
(一)设计引物(1) Design primers
在实施例1获得基因序列基础上,设计荧光定量PCR检测用引物序列如下:On the basis of the gene sequence obtained in Example 1, the primer sequences for fluorescent quantitative PCR detection were designed as follows:
NtHQT2-Q-F:5 '-AGTATCATCCTCCTCCATCT-3 ';NtHQT2-Q-F: 5'-AGTATCATCCTCCTCCATCT-3';
NtHQT2-Q-R:5 '-TTCGTAAGTGCTACCATCAT-3 ';NtHQT2-Q-R: 5'-TTCGTAAGTGCTACCATCAT-3';
NtHQT3-Q-F:5 '-TACTTCTGGTGACATCTCTTC-3 ';NtHQT3-Q-F: 5'-TACTTCTGGTGACATCTCTTC-3';
NtHQT3-Q-R:5 '-GCCGTCAGATAATGTATGGA-3 ';NtHQT3-Q-R: 5'-GCCGTCAGATAATGTATGGA-3';
荧光定量PCR测定过程中,以L25作为内参基因,对应的,设计引物对如下:In the process of fluorescent quantitative PCR measurement, L25 was used as the internal reference gene, and correspondingly, the primer pair was designed as follows:
L25-F:5 '-CCCCTCACCACAGAGTCTGC-3 ';L25-F: 5'-CCCCTCACCACAGAGTCTGC-3';
L25-R:5 '-AAGGGTGTTGTTGTCCTCAATCTT-3 '。L25-R: 5'-AAGGGTGTTGTTGTCCTCAATCTT-3'.
(二)取样(2) Sampling
分别以K326盛花期的茎秆、茎节、叶片(5叶、10叶、15叶)、花、花蕾、腋芽、侧根、须根等样品,分别提取RNA并反转录为cDNA备用。The stems, stem nodes, leaves (5 leaves, 10 leaves, 15 leaves), flowers, flower buds, axillary buds, lateral roots, fibrous roots and other samples of K326 in full flowering stage were used to extract RNA and reverse transcribe into cDNA for future use.
(三)荧光定量PCR检测(3) Fluorescent quantitative PCR detection
荧光定量PCR时,20 μL反应体系设计如下:For fluorescent quantitative PCR, the 20 μL reaction system was designed as follows:
cDNA模板,4 μL(40 ng/μL);cDNA template, 4 μL (40 ng/μL);
上、下游引物,各1 μL;Upstream and downstream primers, 1 μL each;
SYBR Green,10 μL;SYBR Green, 10 μL;
ddH2O,4 μL。 ddH2O , 4 μL.
荧光定量检测结果如图1、图2所示。分析可以看出:The results of fluorescence quantitative detection are shown in Figure 1 and Figure 2. Analysis shows that:
NtHQT2基因在普通烟草K326盛花期的根、叶、花等组织中均有表达,但在叶片中的表达量最高,其中又以5叶位的叶片表达量较高;而NtHQT3基因的组织表达模式与NtHQT2基因类似,同样在多个组织器官中有所表达,同样在叶片中表达量最高,但与NtHQT2基因的表达部位显然也有一定区别,例如:NtHQT3基因似乎更集中表达于叶片,而且在第5叶位的叶片中表达含量较高。这一结果也表示了正是由于不同NtHQT基因表达部位的细节性差异,才对叶片中相关次生代谢产物含量发挥了综合性的调节作用。The NtHQT2 gene was expressed in the roots, leaves, flowers and other tissues of the common tobacco K326 at the full flowering stage, but the expression level was the highest in the leaves, and the expression level of the leaves at the 5th leaf position was higher; while the tissue expression pattern of the NtHQT3 gene Similar to the NtHQT2 gene, it is also expressed in multiple tissues and organs, and the expression level is also the highest in leaves, but it is obviously different from the expression site of the NtHQT2 gene. For example, the NtHQT3 gene seems to be more concentrated in the leaves, and in the The expression level was higher in leaves at the 5th leaf position. This result also indicates that it is precisely because of the detailed differences in the expression sites of different NtHQT genes that they play a comprehensive role in regulating the content of related secondary metabolites in leaves.
总体上,仅就组织表达模式而言,这两个基因的组织表达模式具有类似性,即,主要表达于叶片组织中,但这两个基因的表达量以及在华、根等组织器官中的表达情况也表现出了明显差异。In general, only in terms of tissue expression patterns, the tissue expression patterns of these two genes are similar, that is, they are mainly expressed in leaf tissues, but the expression levels of these two genes and their expression levels in tissues and organs such as China and roots are similar. There were also significant differences in expression.
实施例3Example 3
在实施例1、2工作基础上,为较为直观明确NtHQT2基因以及NtHQT3基因与烟叶中绿原酸含量表型之间关系,发明人利用CRISPER/Cas9基因编辑技术分别对NtHQT2、NtHQT3基因进行了基因编辑(基因沉默),对NtHQT2、NtHQT3基因表达量进行了下调,在此基础上,对不同基因表达量情况下所导致的烟叶中绿原酸含量变化情况进行了检测分析。主要技术操作过程为:首先分别构建针对NtHQT2、NtHQT3基因的基因编辑载体;然后将该基因编辑载体转化农杆菌;利用农杆菌介导的遗传转化技术转化烟草,对转化烟草进行卡那基因抗性筛选后,获得阳性转基因烟草,继续培育至结种子;将所获得种子再行种植(T1代烟株),并对转基因植株中绿原酸代谢物情况进行分析,具体实验情况简介如下。On the basis of the work in Examples 1 and 2, in order to more intuitively clarify the relationship between the NtHQT2 gene and NtHQT3 gene and the chlorogenic acid content phenotype in tobacco leaves, the inventors used the CRISPER/Cas9 gene editing technology to genetically modify the NtHQT2 and NtHQT3 genes respectively. Editing (gene silencing) down-regulated the expression of NtHQT2 and NtHQT3 genes. On this basis, the changes of chlorogenic acid content in tobacco leaves caused by different gene expression were detected and analyzed. The main technical operation process is as follows: first construct gene editing vectors targeting NtHQT2 and NtHQT3 genes respectively; then transform the gene editing vectors into Agrobacterium; use Agrobacterium-mediated genetic transformation technology to transform tobacco, and carry out kana gene resistance on transformed tobacco After screening, the positive transgenic tobacco was obtained, and continued to grow until it set seeds; the obtained seeds were planted again (T1 generation tobacco plants), and the metabolites of chlorogenic acid in the transgenic plants were analyzed. The specific experimental conditions are as follows.
(一)基因编辑载体的构建(1) Construction of gene editing vector
根据实施例1测序所得NtHQT2、NtHQT3基因的基因组和编码区序列,参考基因编辑靶位点设计原则,分别在NtHQT2、NtHQT3基因的第一个外显子序列上设计20 bp左右的靶位点(示意图如图3、图4所示),分别设计敲除的引物序列如下:According to the genome and coding region sequences of NtHQT2 and NtHQT3 genes sequenced in Example 1, and referring to the design principles of gene editing target sites, target sites of about 20 bp were designed on the first exon sequences of NtHQT2 and NtHQT3 genes ( The schematic diagrams are shown in Figure 3 and Figure 4), and the knockout primer sequences were designed as follows:
NtHQT2-C-F:GATTGTTGAGGTCTGATTTGAGGAG;NtHQT2-C-F: GATTGTTGAGGTCTGATTTGAGGAG;
NtHQT2-C-R:AAACCTCCTCAAATCAGACCTCAAC;NtHQT2-C-R:AAACCTCCTCAAATCAGACCTCAAC;
NtHQT3-C-F:GATTGTCAAATTTGGATTTAATAGT;NtHQT3-C-F:GATTGTCAAATTTGGATTTAATAGT;
NtHQT3-C-R:AAACACTATTAAATCCAAATTTGAC;NtHQT3-C-R: AAACACTATTAAATCCAAATTTGAC;
随后,PCR扩增获取靶位点的DNA双链;20μL反应体系参考设计如下:Subsequently, PCR amplification was used to obtain the DNA double strands of the target site; the reference design of the 20 μL reaction system is as follows:
上、下游引物,各4 μL(50 μmol/L);Upstream and downstream primers, 4 μL each (50 μmol/L);
Annealing Buffer for DNA Oligos(5×),4 μL;Annealing Buffer for DNA Oligos (5×), 4 μL;
ddH2O补足至20 µL;Make up to 20 µL with ddH 2 O;
反应程序:95℃、5 min,每8s下降0.1℃,直至25℃;反应产物4℃保存备用。Reaction program: 95°C for 5 min, drop by 0.1°C every 8s until 25°C; store the reaction product at 4°C for future use.
再后,将上述PCR反应得到的退火产物与质粒pORE-Cas9/gRNA(预先用BsaI酶切)进行连接;10 µL连接体系参考为:Then, ligate the annealed product obtained from the above PCR reaction with the plasmid pORE-Cas9/gRNA (pre-digested with BsaI); the reference for 10 µL ligation system is:
酶切载体,3 µL;Digested vector, 3 µL;
退火产物,2 µL;Annealed product, 2 µL;
Solution I,5 µL;Solution I, 5 µL;
16 ℃连接30 min。Incubate at 16°C for 30 min.
再后,将上述连接产物转化DH5α感受态细胞并进行抗性筛选培养(37℃培养12h左右)。Then, the above ligation product was transformed into DH5α competent cells and cultured for resistance selection (37°C for about 12 hours).
最后,挑选阳性克隆进行菌落PCR鉴定后,进一步将鉴定正确的质粒送北京六合华大基因科技有限公司进行测序鉴定,确保质粒重组正确。Finally, after positive clones were selected for colony PCR identification, the correctly identified plasmids were further sent to Beijing Liuhe Huada Gene Technology Co., Ltd. for sequencing identification to ensure correct plasmid recombination.
需要说明的是,菌落PCR鉴定中,针对NtHQT2编辑载体,鉴定用引物对设计为:It should be noted that in the colony PCR identification, for the NtHQT2 editing vector, the primer pair for identification was designed as follows:
U26-jiance-F:5'-TTAGGTTTACCCGCCAATA-3',U26-jiance-F: 5'-TTAGGTTTACCCGCCAATA-3',
NtHQT2-C-R:5'-AAACCTCCTCAAATCAGACCTCAAC-3';NtHQT2-C-R: 5'-AAACCTCCTCAAATCAGACCTCAAC-3';
针对NtHQT3编辑载体,鉴定用引物对设计为:For the NtHQT3 editing vector, the primer pair for identification is designed as follows:
U26-jiance-F:5'-TTAGGTTTACCCGCCAATA-3',U26-jiance-F: 5'-TTAGGTTTACCCGCCAATA-3',
NtHQT3-C-R:5'-AAACATCTCCCAGCCATTGGATAAC-3'。NtHQT3-C-R: 5'-AAACATCTCCCAGCCATTGGATAAC-3'.
(二)制备转染液(2) Preparation of transfection solution
将步骤(一)所制备编辑载体转入农杆菌LBA4404,并进一步制备转染液。具体操作参考如下。The editing vector prepared in step (1) was transformed into Agrobacterium LBA4404, and the transfection solution was further prepared. The specific operation is as follows.
首先,取1 μl基因编辑载体,加入含100 µl的农杆菌感受态细胞的离心管中,冰上放置30分钟后,转入液氮速冻1分钟,随后37℃温育5分钟;First, take 1 μl of the gene editing vector, add it to a centrifuge tube containing 100 μl of Agrobacterium competent cells, place it on ice for 30 minutes, transfer to liquid nitrogen for quick freezing for 1 minute, and then incubate at 37°C for 5 minutes;
随后,加入1 ml LB液体培养基,28℃震荡培养3小时;培养结束后,5000 rpm离心1分钟,弃去上清(培养基),加入200 μl LB液体培养基,重悬沉淀;Then, add 1 ml LB liquid medium, shake and culture at 28°C for 3 hours; after the culture, centrifuge at 5000 rpm for 1 minute, discard the supernatant (medium), add 200 μl LB liquid medium, and resuspend the pellet;
最后,取200 μl重悬菌液均匀地涂于含20 mg / L Rif和50 mg / L卡那霉素(Kan)的LB固体平板上,28℃培养2-3天后,挑选阳性质粒扩增后进行菌落PCR鉴定,确保质粒转化正确,并将转化正确的重组菌株保存备用。对转化正确菌株进一步摇菌扩增、离心收集菌体后,再用MSO重悬制备作为转染液备用。(相关操作参考现有技术常规操作即可,不再赘述)。Finally, take 200 μl of the resuspended bacteria and evenly spread it on the LB solid plate containing 20 mg/L Rif and 50 mg/L Kanamycin (Kan). After culturing at 28°C for 2-3 days, select positive plasmids for amplification Afterwards, carry out colony PCR identification to ensure that the plasmid is transformed correctly, and save the transformed recombinant strain for future use. The correct transformed strains were further shaken to amplify, centrifuged to collect the bacteria, and then resuspended with MSO to prepare as a transfection solution for later use. (For related operations, please refer to conventional operations in the prior art, and details will not be repeated).
需要说明的是,农杆菌感受态细胞可参考如下操作进行制备:It should be noted that Agrobacterium competent cells can be prepared by referring to the following operations:
首先,挑取单菌落的农杆菌LBA4404在2ml LB(含20 mg/mL Rif)中28℃培养过夜;First, pick a single colony of Agrobacterium LBA4404 and culture it overnight at 28°C in 2ml LB (containing 20 mg/mL Rif);
随后,取生长良好的菌液2 ml(含25 mg/L Rif)接种于50 ml LB液体培养基中,28℃振荡培养至OD600=0.5左右;Then, inoculate 2 ml of well-grown bacteria solution (containing 25 mg/L Rif) into 50 ml LB liquid medium, and culture with shaking at 28°C until OD600=0.5;
再后,将菌液转移至50 ml离心管内,冰上放30分钟后,4℃、5000 rpm离心5min以收集菌体;Then, transfer the bacterial solution to a 50 ml centrifuge tube, put it on ice for 30 minutes, and then centrifuge at 5000 rpm for 5 minutes at 4°C to collect the bacterial cells;
再后,用10ml、0.15M预冷的氯化钠溶液轻悬菌体后,4℃、5000 rpm离心5min收集菌体;Then, after lightly suspending the bacteria in 10ml, 0.15M pre-cooled sodium chloride solution, centrifuge at 5000 rpm for 5 minutes at 4°C to collect the bacteria;
最后,加入20 ml预冷的20 mM氯化钙溶液悬浮菌体完成感受态细胞制备;将此制备完成的感受态细胞以100 µl/管分装后,-80℃保存备用。Finally, 20 ml of pre-cooled 20 mM calcium chloride solution was added to suspend the cells to complete the preparation of competent cells; the prepared competent cells were divided into 100 μl/tube and stored at -80°C for later use.
(三)转化烟草(3) Transformed Tobacco
采用组培再生方法转化烟草(具体过程委托相关公司进行操作),具体操作参考如下。The tissue culture regeneration method is used to transform tobacco (the specific process is entrusted to a relevant company to operate), and the specific operation is as follows.
首先,取生长旺盛的烟草叶片,消毒灭菌后剪成1 cm2左右小块,置于培养基中预培养2天后,置于步骤(二)所制备的侵染液中充分侵染10-15min左右;First, take vigorously growing tobacco leaves, cut them into small pieces of about 1 cm 2 after disinfection and sterilization, place them in the medium for pre-cultivation for 2 days, and then place them in the infection solution prepared in step (2) to fully infect 10- About 15 minutes;
随后,将上述侵染后叶块置于培养基中暗培养4天后,转入培养基中诱导分化,以诱导形成丛生不定芽切(期间,根据需要每隔10天更换1次培养基,同时培养基中加入有抗生素进行抗性筛选);Subsequently, the above-mentioned infected leaf pieces were placed in the medium for dark culture for 4 days, and then transferred to the medium to induce differentiation to induce the formation of clustered adventitious bud cuts (during this period, the medium was changed every 10 days as needed, and at the same time Antibiotics were added to the culture medium for resistance screening);
待不定芽长至1-2cm时,将丛生不定芽分切成单个小芽,并进一步转入培养基中诱导生根;When the adventitious buds grow to 1-2cm, the clustered adventitious buds are divided into individual small buds, and further transferred to the medium to induce rooting;
最后,待根系发育生长完成后,将组培苗取出,转移到盛有疏松无菌土的花盆中,常规管理培养。Finally, after the development and growth of the root system is completed, the tissue cultured seedlings are taken out, transferred to flowerpots filled with loose sterile soil, and routinely managed and cultivated.
针对转化后的转基因组培再生苗,采集适量再生烟株叶片作为样品,提取其基因组DNA,采用PCR方法检测确认外源DNA片段是否插入到植物基因组中。For the transformed transgenic tissue-cultured regenerated seedlings, an appropriate amount of leaves of regenerated tobacco plants were collected as samples, and their genomic DNA was extracted, and PCR method was used to detect whether the exogenous DNA fragments were inserted into the plant genome.
PCR扩增验证时,引物设计如下:For PCR amplification verification, the primers were designed as follows:
Cas9-F:5'-GGGACCCTAAGAAGTACGGC-3',Cas9-F: 5'-GGGACCCTAAGAAGTACGGC-3',
Cas9-R:5'-TATTCTCGGCCTGCTCTCTG-3';Cas9-R:5'-TATTCTCGGCCTGCTCTCTG-3';
25 μL反应体系参考设计为:The 25 μL reaction system reference design is:
基因上、下游引物,各1 µL(10 µmol/L);Gene upstream and downstream primers, 1 µL each (10 µmol/L);
DNA模板,1 µL(100 ng/µL);DNA template, 1 µL (100 ng/µL);
10×Taq Buffer(Mg2+),2.5 µL;10×Taq Buffer (Mg 2+ ), 2.5 µL;
dNTPs,2 µL(2.5 mmol/L);dNTPs, 2 µL (2.5 mmol/L);
Taq DNA polymerase,0.25 µL;Taq DNA polymerase, 0.25 µL;
ddH2O补足至25 µL;Make up to 25 µL with ddH 2 O;
PCR反应程序:94℃预变性5 min;94℃变性30 s,54℃退火30 s,72℃延伸20 s,30个循环;72℃延伸10 min;4℃保存。PCR reaction program: pre-denaturation at 94°C for 5 min; denaturation at 94°C for 30 s, annealing at 54°C for 30 s, extension at 72°C for 20 s, 30 cycles; extension at 72°C for 10 min; storage at 4°C.
PCR结束后,对PCR扩增产物进行1%琼脂糖凝胶电泳检测,确定外源DNA片段(as9蛋白)是否插入植物基因组中。After the PCR is completed, the PCR amplification product is detected by 1% agarose gel electrophoresis to determine whether the exogenous DNA fragment (as9 protein) is inserted into the plant genome.
针对上述初步PCR筛选确定的转基因阳性植株,为进一步确定目的基因是否成功被编辑并发生突变,并具体确认突变类型,发明人做了进一步检测鉴定,具体情况简介如下。In order to further determine whether the target gene was successfully edited and mutated for the transgenic positive plants identified by the above preliminary PCR screening, and to confirm the type of mutation, the inventor conducted further detection and identification, and the specific situation is as follows.
首先,根据NtHQT2基因序列及靶位点位置,设计检测用引物对如下:First, according to the NtHQT2 gene sequence and the position of the target site, the primer pair for detection was designed as follows:
NtHQT2-BJ-F:5'-ggagtgagtacggtgtgcAAACCAACACCAACAAAGAG-3',NtHQT2-BJ-F:5'-ggagtgagtacggtgtgcAAACCAACACCAACAAAGAG-3',
NtHQT2-BJ-R:5'-gagttggatgctggatggTCTTCCTTGTTCATCTCTAGC-3';NtHQT2-BJ-R:5'-gagttggatgctggatggTCTTCCTTGTTCATCTCTAGC-3';
根据NtHQT2基因序列及靶位点位置,设计检测用引物对如下:According to the NtHQT2 gene sequence and the position of the target site, the primer pair for detection was designed as follows:
NtHQT3-BJ-F:5'-ggagtgagtacggtgtgcAACCATCAAAGCCAACTC-3',NtHQT3-BJ-F:5'-ggagtgagtacggtgtgcAACCATCAAAGCCAACTC-3',
NtHQT3-BJ-R:5'-gagttggatgctggatggATTATCCTTAGCCAATCTCC-3';NtHQT3-BJ-R:5'-gagttggatgctggatggATTATCCTTAGCCAATCTCC-3';
随后,以上述Cas9 阳性转基因植物DNA为模板,进行PCR扩增;Subsequently, using the above-mentioned Cas9 positive transgenic plant DNA as a template, carry out PCR amplification;
50 μL扩增体系参考设计为:The 50 μL amplification system reference design is:
上、下游引物,各2 µL(10 µmol/L);Upstream and downstream primers, 2 µL each (10 µmol/L);
DNA模板,2 µL(100 ng/µL);DNA template, 2 µL (100 ng/µL);
10 × Taq Buffer(Mg2 +),5 µL;10 × Taq Buffer (Mg 2 + ), 5 µL;
dNTPs ,4 µL(2.5 mmol/L);dNTPs, 4 µL (2.5 mmol/L);
Taq DNA polymerase,0.5 µL;Taq DNA polymerase, 0.5 µL;
ddH2O补足至50 µL;Make up to 50 µL with ddH 2 O;
PCR反应程序: 94℃预变性5 min;94℃变性30 s,59℃退火30 s,72℃延伸20 s,35个循环;72℃延伸10 min,4℃保存;PCR reaction program: pre-denaturation at 94°C for 5 min; denaturation at 94°C for 30 s, annealing at 59°C for 30 s, extension at 72°C for 20 s, 35 cycles; extension at 72°C for 10 min, storage at 4°C;
对PCR扩增产物进行电泳检测后,回收、纯化PCR产物,并送西安青雪生物科技有限公司进行Hi-TOM测序,根据测序结果比对分析基因的突变率。After the PCR amplification products were detected by electrophoresis, the PCR products were recovered and purified, and sent to Xi'an Qingxue Biotechnology Co., Ltd. for Hi-TOM sequencing, and the mutation rate of the gene was compared and analyzed according to the sequencing results.
部分测序结果如图5、图6所示。分析结果表明:Part of the sequencing results are shown in Figure 5 and Figure 6. The results show that:
针对NtHQT2转基因植株,在11株T0代植株中有3种类型的基因突变,分别是1个和8个碱基的删除,以及1个碱基的插入。这些碱基突变均发生在敲除的靶位点上,而野生型植株的NtHQT2基因未检测到任何突变。这说明T0代植株已经实现了以碱基删除或者插入的形式对NtHQT2基因进行突变。For the NtHQT2 transgenic plants, there were 3 types of gene mutations in the 11 T0 generation plants, which were deletions of 1 and 8 bases, and insertions of 1 base. These base mutations all occurred at the knockout target site, but no mutation was detected in the NtHQT2 gene of wild-type plants. This shows that the plants of the T0 generation have mutated the NtHQT2 gene in the form of base deletion or insertion.
针对NtHQT3转基因植株,在9株T0代植株中有4种类型的基因突变,分别是1个碱基的插入,1个、2个和3个碱基的删除。这些碱基突变均发生在敲除的靶位点上,而野生型植株的NtHQT3基因未检测到任何突变。这说明T0代植株已经实现了以碱基删除或者插入的形式对NtHQT3基因进行了突变。For NtHQT3 transgenic plants, there were 4 types of gene mutations in 9 T0 generation plants, which were 1 base insertion, 1, 2 and 3 base deletions. These base mutations all occurred at the knockout target site, but no mutation was detected in the NtHQT3 gene of wild-type plants. This shows that the plants of the T0 generation have mutated the NtHQT3 gene in the form of base deletion or insertion.
为了验证相关表型能否稳定的遗传到下一代,收集T0代阳性植株的种子,继续种植后获得T2代植株,并进行检测分析。结果表明:T0代植株能稳定的遗传到T2代。In order to verify whether the relevant phenotype can be stably inherited to the next generation, the seeds of the positive plants of the T0 generation were collected, and the T2 generation plants were obtained after continued planting, and the detection and analysis were carried out. The results showed that: T0 generation plants can be stably inherited to T2 generation.
实施例4Example 4
在上述实施例工作基础上,为进一步验证明确NtHQT2基因以及NtHQT3基因与烟叶中绿原酸含量表型之间关系,发明人构建了相关超表达载体,对NtHQT2、NtHQT3基因表达量进行了上调,对不同基因表达量情况下所导致的烟叶中绿原酸含量变化情况进行了进一步检测分析。具体实验情况简介如下。Based on the work in the above examples, in order to further verify the relationship between the NtHQT2 gene and NtHQT3 gene and the chlorogenic acid content phenotype in tobacco leaves, the inventor constructed a related overexpression vector to up-regulate the expression of NtHQT2 and NtHQT3 genes, The changes of chlorogenic acid content in tobacco leaves caused by different gene expression levels were further detected and analyzed. The specific experimental situation is briefly introduced as follows.
(一)构建超表达载体(1) Construction of overexpression vector
首先,设计PCR扩增用引物对如下:First, design the primer pair for PCR amplification as follows:
针对NtHQT2基因,For the NtHQT2 gene,
上游引物:5'- GGATCCATGGGAAGTGAAAAGATGAT-3',Upstream primer: 5'- GGATCCATGGGAAGTGAAAAGATGAT-3',
下游引物:5'-CCATGGTCAAAATTCATACAAATACTT-3';Downstream primer: 5'-CCATGGTCAAAAATTCATACAAATACTT-3';
针对NtHQT3基因,For the NtHQT3 gene,
上游引物:5'-TCTAGAATGAAGATCGACATTAAGG-3',Upstream primer: 5'-TCTAGAATGAAGATCGACATTAAGG-3',
下游引物:5'-GGTACCTCAAAAGTCATACAGGTACT-3';Downstream primer: 5'-GGTACCTCAAAAAGTCATACAGGTACT-3';
随后,以实施例1中测序正确含有NtHQT2(或NtHQT3)基因的T质粒为模板进行PCR扩增,并回收扩增产物;Subsequently, PCR amplification was performed using the T plasmid correctly sequenced in Example 1 containing the NtHQT2 (or NtHQT3) gene as a template, and the amplified product was recovered;
再后,对的PCR产物进行酶切(针对NtHQT2基因,进行BamH I、Nco I双酶切,针对NtHQT3基因,进行Xba 1、Kpn 1双酶切),并将酶切片段和 pCAMBIA1300空载体载体连接;Then, the PCR product was digested (for the NtHQT2 gene, BamH I and Nco I double enzyme digestion was performed, and for the NtHQT3 gene,
最后,将连接产物转化大肠杆菌DH5α。并进行抗性筛选和鉴定,确保质粒重组正确。Finally, the ligated product was transformed into Escherichia coli DH5α. And carry out resistance screening and identification to ensure correct plasmid recombination.
相关操作参考前述或现有技术即可,不再赘述。Relevant operations can refer to the foregoing or existing technologies, and will not be repeated here.
(二)制备转染液(2) Preparation of transfection solution
相关操作参考实施例3即可,不再赘述。For related operations, refer to
(三)转化烟草(3) Transformed Tobacco
与实施例3类似,采用组培再生方法转化烟草,具体操作不再赘述。Similar to Example 3, the tissue culture regeneration method was used to transform tobacco, and the specific operation will not be repeated.
需要说明的是,对转基因阳性植株进行PCR鉴定时:It should be noted that when performing PCR identification on transgenic positive plants:
针对NtHQT2基因,引物对设计为(上游引物特异性结合NtHQT2基因,下游引物特异性结合GFP标签):For the NtHQT2 gene, the primer pair was designed as (the upstream primer specifically binds to the NtHQT2 gene, and the downstream primer specifically binds to the GFP tag):
上游引物:5'-TTGCCACCAGGTTACTTAG-3';Upstream primer: 5'-TTGCCACCAGGTTACTTAG-3';
下游引物:5'-CGTCGTCCTTGAAGAAGAT-3';Downstream primer: 5'-CGTCGTCCTTGAAGAAGAT-3';
针对NtHQT3基因,引物对设计为(上游引物特异性结合NtHQT3基因,下游引物特异性结合GFP标签):For the NtHQT3 gene, the primer pair is designed as (the upstream primer specifically binds to the NtHQT3 gene, and the downstream primer specifically binds to the GFP tag):
上游引物:5'-AAGAATGGACGACGAATACT-3'。Upstream primer: 5'-AAGAATGGACGACGAATACT-3'.
下游引物:5'-ATGGCGGACTTGAAGAAG-3';Downstream primer: 5'-ATGGCGGACTTGAAGAAG-3';
以对照和K326和T0代幼苗基因组DNA为模板进行PCR扩增,扩增出特异性条带的为T0代阳性幼苗。The genomic DNA of the control, K326 and T0 generation seedlings were used as templates for PCR amplification, and the positive seedlings of the T0 generation were amplified with specific bands.
进一步地,以烟草L25基因为内参基因,利用qPCR方法检测阳性转基因幼苗中NtHQT2(NtHQT3)基因的表达水平;检测时,相关引物设计如下:Further, using the tobacco L25 gene as an internal reference gene, the expression level of NtHQT2 (NtHQT3) gene in positive transgenic seedlings was detected by qPCR method; when detecting, the relevant primers were designed as follows:
针对NtHQT2基因:Targeting the NtHQT2 gene:
上游引物:5'-AGTATCATCCTCCTCCATCT-3' ,Upstream primer: 5'-AGTATCATCCTCCTCCATCT-3',
下游引物:5'- TTCGTAAGTGCTACCATCAT-3' ;Downstream primer: 5'-TTCGTAAGTGCTACCATCAT-3';
针对NtHQT3基因:Targeting the NtHQT3 gene:
上游引物:5'-TACTTCTGGTGACATCTCTTC-3'Upstream primer: 5'-TACTTCTGGTGACATCTCTTC-3'
下游引物:5'- GCCGTCAGATAATGTATGGA-3' ;Downstream primer: 5'-GCCGTCAGATAATGTATGGA-3';
针对L25内参基因:For L25 internal reference gene:
上游引物:5'-CCCCTCACCACAGAGTCTGC-3',Upstream primer: 5'-CCCCTCACCACAGAGTCTGC-3',
下游引物:5'- AAGGGTGTTGTTGTCCTCAATCTT-3';Downstream primer: 5'- AAGGGTGTTGTTGTCCTCAATCTT-3';
最后,根据qPCR得到的CT值,用2-△△CT方法计算NtHQT2、NtHQT3基因的相对表达量。Finally, according to the CT values obtained by qPCR, the relative expression levels of NtHQT2 and NtHQT3 genes were calculated using the 2-△△CT method.
实施例5Example 5
针对实施例3、实施例4所获得的转基因株系,发明人进行了进一步的表型观察和绿原酸含量检测,相关结果简介如下。For the transgenic lines obtained in Example 3 and Example 4, the inventors conducted further phenotype observation and detection of chlorogenic acid content, and the relevant results are as follows.
(一)生长表型情况(1) Growth phenotype
部分典型表型对比结果如图7、图8所示。对比可以看出:The comparison results of some typical phenotypes are shown in Figure 7 and Figure 8. It can be seen from the comparison:
针对NtHQT2基因而言,相关生长表型统计结果表明:超表达NtHQT2基因后,株高较对照K326比平均增加12.5 cm,总的有效叶片数减少3-4片,开花时间提前约10天,中部最大叶片的叶长增加8.2 cm,叶宽增加13.7 cm变大;而NtHQT2基因编辑植株表型变化不大;For the NtHQT2 gene, the statistical results of related growth phenotypes showed that after overexpressing the NtHQT2 gene, the plant height increased by an average of 12.5 cm compared with the control K326, the total number of effective leaves decreased by 3-4 pieces, and the flowering time was about 10 days earlier. The leaf length of the largest leaf increased by 8.2 cm, and the leaf width increased by 13.7 cm; while the phenotype of the NtHQT2 gene-edited plants did not change much;
即:针对NtHQT2基因的编辑(基因沉默),并不会导致相关生长表型的明显差异,但超表达该基因后,可以明显增加株高、促进提前开花、在减少总有效叶片同时增加中部叶位叶片面积;That is: editing (gene silencing) targeting the NtHQT2 gene does not lead to significant differences in related growth phenotypes, but overexpression of the gene can significantly increase plant height, promote early flowering, and increase the number of middle leaves while reducing total effective leaves. bit leaf area;
针对NtHQT3基因而言,其生长表型情况与NtHQT2基因类似,但在具体表型差异数据方面也有明显差异,具体而言:株高较较对照K326比平均增加12.0 cm,总叶片数减少约3片,开花时间提前约7天,中部最大叶片的叶长增加4.6 cm,叶宽增加12.8 cm变大;而NtHQT3基因编辑植株和对照K326表型变化不大;For the NtHQT3 gene, its growth phenotype is similar to that of the NtHQT2 gene, but there are also significant differences in the specific phenotypic difference data. Specifically, the plant height increased by an average of 12.0 cm compared with the control K326, and the total number of leaves decreased by about 3 , the flowering time was about 7 days earlier, the leaf length of the largest leaf in the middle increased by 4.6 cm, and the leaf width increased by 12.8 cm; while the phenotype of NtHQT3 gene-edited plants and control K326 did not change much;
即,针对NtHQT3基因的编辑(基因沉默),并不会导致相关生长表型的明显差异,但超表达该基因后,可以明显增加株高、促进提前开花、在减少总有效叶片同时增加中部叶位叶片面积;(但相关株高增加幅度、开花提前时间、叶片增加面积程度等表型效果数据小于NtHQT2基因)That is, editing (gene silencing) targeting the NtHQT3 gene does not lead to significant differences in related growth phenotypes, but overexpression of the gene can significantly increase plant height, promote early flowering, and increase the number of middle leaves while reducing total effective leaves. Leaf area; (however, the phenotypic effect data such as the increase in plant height, the early flowering time, and the degree of leaf area increase are smaller than those of the NtHQT2 gene)
(二)基因表达量情况(2) Gene expression level
部分转基因株系NtHQT2、NtHQT3基因表达情况如图9、图11所示。可以看出:超表达株系中NtHQT2、NtHQT3基因表达量得到了明显提升。The gene expressions of NtHQT2 and NtHQT3 in some transgenic lines are shown in Fig. 9 and Fig. 11 . It can be seen that the expression levels of NtHQT2 and NtHQT3 genes in the overexpression lines have been significantly improved.
(三)绿原酸含量情况(3) Chlorogenic acid content
采用GC-MS分析方法,发明人检测了转基因株系中绿原酸含量情况,检测时,HPLC-UV绝对定量分析条件:色谱柱Symmetry C18(4.6×250 mm,5 µm),检测波长340 nm,进样量5 µL,流速1.0 mL/min;Using the GC-MS analysis method, the inventor detected the content of chlorogenic acid in the transgenic lines. During the detection, the HPLC-UV absolute quantitative analysis conditions: chromatographic column Symmetry C18 (4.6×250 mm, 5 µm), detection wavelength 340 nm ,
流动相A为水/甲醇/乙酸(44/5/1,v/v/v),流动相B为甲醇/水/乙酸(44/5/1,v/v/v);Mobile phase A is water/methanol/acetic acid (44/5/1, v/v/v), mobile phase B is methanol/water/acetic acid (44/5/1, v/v/v);
梯度洗脱:Gradient elution:
0~15.0 min,10%B-30%B;0~15.0 min, 10%B-30%B;
15.0~26.0 min,30%B-90%B;15.0~26.0 min, 30%B-90%B;
26.0~28.0 min,90%B;26.0~28.0 min, 90% B;
28.1-35.0 min,10%B。28.1-35.0 min, 10% B.
结果表明,针对NtHQT2基因株系(如图10):The results showed that for the NtHQT2 gene strains (as shown in Figure 10):
T2代基因编辑植株(BJ1、BJ2、BJ3)和对照(K326)相比,中部叶成熟期中部叶片绿原酸含量下降了34.6%、29.1%和21.5%,T2代过表达烟草植株(OE-1、OE-2、OE-3)中部叶成熟期绿原酸的含量和对照(K326)相比,分别增加了71.2%、82.4%和101.7%。这一结果表明,NtHQT2基因在烟草绿原酸合成中具有重要的作用。Compared with the control (K326) gene-edited plants of the T2 generation (BJ1, BJ2, BJ3), the content of chlorogenic acid in the middle leaf of the middle leaf mature stage decreased by 34.6%, 29.1% and 21.5%, and the overexpressed tobacco plants of the T2 generation (OE- 1, OE-2, OE-3) Compared with the control (K326), the content of chlorogenic acid in the middle leaf maturity stage increased by 71.2%, 82.4% and 101.7%, respectively. This result indicated that NtHQT2 gene plays an important role in the synthesis of tobacco chlorogenic acid.
针对NtHQT3基因株系:和对照(K326)相比,T2代过表达NtHQT4的转基因植株(OE-1、OE-2、OE-3)中部叶成熟期第10叶位的叶片中绿原酸含量增加了98.1%、81.2%和101.7%。T2代基因编辑植株(BJ1、BJ2、BJ3)中部叶成熟期第10叶位的叶片中绿原酸含量下降了15.4%、22.0%和28.2%。这一结果表明,利用NtHQT3基因在烟草绿原酸合成中具有重要的作用。For the NtHQT3 gene line: Compared with the control (K326), the content of chlorogenic acid in the leaves of the 10th leaf position in the middle leaf maturity stage of the T2 transgenic plants (OE-1, OE-2, OE-3) overexpressing NtHQT4 An increase of 98.1%, 81.2% and 101.7%. The content of chlorogenic acid in the 10th leaf position of the T2 generation gene-edited plants (BJ1, BJ2, BJ3) decreased by 15.4%, 22.0% and 28.2% at the middle leaf maturity stage. This result indicated that the use of NtHQT3 gene plays an important role in tobacco chlorogenic acid synthesis.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310039140.9A CN116240225B (en) | 2023-01-12 | 2023-01-12 | Series tobacco NtHQT gene and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310039140.9A CN116240225B (en) | 2023-01-12 | 2023-01-12 | Series tobacco NtHQT gene and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116240225A true CN116240225A (en) | 2023-06-09 |
CN116240225B CN116240225B (en) | 2025-05-02 |
Family
ID=86634277
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310039140.9A Active CN116240225B (en) | 2023-01-12 | 2023-01-12 | Series tobacco NtHQT gene and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116240225B (en) |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004001028A1 (en) * | 2002-06-21 | 2003-12-31 | Plant Bioscience Limited | Plant-derived transferase genes |
US20090158456A1 (en) * | 2005-10-07 | 2009-06-18 | Nestec S.A. | Polynucleotides Encoding Phenylpropanoid Pathway Enzymes in Coffee |
KR20130034116A (en) * | 2011-09-28 | 2013-04-05 | 건국대학교 산학협력단 | Synthesis of chlorogenic acid using transformant |
CN103119170A (en) * | 2010-07-16 | 2013-05-22 | 巴斯夫植物科学有限公司 | Plants with enhanced yield-related traits and methods for their preparation |
US20180119163A1 (en) * | 2016-10-07 | 2018-05-03 | Altria Client Services Llc | Composition and Methods for Producing Tobacco Plants and Products Having Reduced Tobacco-Specific Nitrosamines (TSNAs) |
CN110760519A (en) * | 2018-07-28 | 2020-02-07 | 中国烟草总公司郑州烟草研究院 | Gene for regulating and controlling synthesis of chlorogenic acid and encoding protein and application thereof |
CN110904067A (en) * | 2019-12-20 | 2020-03-24 | 中国烟草总公司郑州烟草研究院 | Tobacco chlorogenic acid synthetic gene NtHQT and application thereof |
CN111690670A (en) * | 2020-07-23 | 2020-09-22 | 江苏省农业科学院 | Sweet potato chlorogenic acid synthesis pathway key enzyme gene IbHCT1 and application thereof |
CN112391397A (en) * | 2020-11-25 | 2021-02-23 | 云南中烟工业有限责任公司 | Tobacco flavone monooxygenase gene NtCYP75B2 and application thereof |
CN117645981A (en) * | 2023-11-07 | 2024-03-05 | 江南大学 | Preparation and application of tobacco-derived hydroxycinnamoyl-coenzyme A quinic acid transferase mutant |
-
2023
- 2023-01-12 CN CN202310039140.9A patent/CN116240225B/en active Active
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004001028A1 (en) * | 2002-06-21 | 2003-12-31 | Plant Bioscience Limited | Plant-derived transferase genes |
US20090158456A1 (en) * | 2005-10-07 | 2009-06-18 | Nestec S.A. | Polynucleotides Encoding Phenylpropanoid Pathway Enzymes in Coffee |
CN103119170A (en) * | 2010-07-16 | 2013-05-22 | 巴斯夫植物科学有限公司 | Plants with enhanced yield-related traits and methods for their preparation |
KR20130034116A (en) * | 2011-09-28 | 2013-04-05 | 건국대학교 산학협력단 | Synthesis of chlorogenic acid using transformant |
US20180119163A1 (en) * | 2016-10-07 | 2018-05-03 | Altria Client Services Llc | Composition and Methods for Producing Tobacco Plants and Products Having Reduced Tobacco-Specific Nitrosamines (TSNAs) |
CN110760519A (en) * | 2018-07-28 | 2020-02-07 | 中国烟草总公司郑州烟草研究院 | Gene for regulating and controlling synthesis of chlorogenic acid and encoding protein and application thereof |
CN110904067A (en) * | 2019-12-20 | 2020-03-24 | 中国烟草总公司郑州烟草研究院 | Tobacco chlorogenic acid synthetic gene NtHQT and application thereof |
CN111690670A (en) * | 2020-07-23 | 2020-09-22 | 江苏省农业科学院 | Sweet potato chlorogenic acid synthesis pathway key enzyme gene IbHCT1 and application thereof |
CN112391397A (en) * | 2020-11-25 | 2021-02-23 | 云南中烟工业有限责任公司 | Tobacco flavone monooxygenase gene NtCYP75B2 and application thereof |
CN117645981A (en) * | 2023-11-07 | 2024-03-05 | 江南大学 | Preparation and application of tobacco-derived hydroxycinnamoyl-coenzyme A quinic acid transferase mutant |
Non-Patent Citations (6)
Title |
---|
NI GGEWEG, R.等: "Nicotiana tabacum mRNA for hydroxycinnamoyl CoA quinate transferase (hqt gene)", GENBANK DATABASE, 10 June 2004 (2004-06-10), pages 582651 * |
RICARDA NIGGEWEG等: "Engineering plants with increased levels of the antioxidant chlorogenic acid", NATURE BIOTECHNOLOGY, vol. 22, no. 6, 25 April 2004 (2004-04-25), pages 3 - 4 * |
李亦君等: "基于 CRISPR/Cas9 技术的烟草 NtHQT2 基因敲除及功能分析", 烟草科技, 20 March 2024 (2024-03-20), pages 1 - 15 * |
李洋;李明;岳玮;丁新华;储昭辉;: "烟草NtHCT基因对次生代谢物质绿原酸和类黄酮合成的影响", 中国烟草学报, no. 06, 31 December 2015 (2015-12-31), pages 127 - 131 * |
杨银菊;陈爱国;刘光亮;张彦;王树声;: "烟草绿原酸生物合成途径关键酶基因的研究进展", 现代农业科技, no. 13, 16 July 2018 (2018-07-16), pages 5 - 8 * |
武明珠;许亚龙;李锋;魏攀;王中;罗朝鹏;王燃;张剑锋;林福呈;杨军;: "烟草绿原酸合成关键基因NtHQT1的克隆及表达分析", 烟草科技, no. 11, 26 November 2015 (2015-11-26), pages 1 * |
Also Published As
Publication number | Publication date |
---|---|
CN116240225B (en) | 2025-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110004154B (en) | Application of tea tree CsJAZ1 gene | |
CN115873086A (en) | Tomato transcription factor SlWOX13 gene and protein and application thereof | |
CN116120413A (en) | SlHAT5 Gene and Its Application in Tomato Resistance to High Temperature Stress | |
CN103665127A (en) | Rice tillering relevant protein, encoding gene thereof and application of rice tillering relevant protein and encoding gene thereof | |
CN110760519B (en) | Gene for regulating and controlling synthesis of chlorogenic acid and encoding protein and application thereof | |
CN114717241A (en) | Rice salt tolerance related gene OsMSRFP and encoding protein and application thereof | |
CN110904067B (en) | Tobacco chlorogenic acid synthetic gene NtHQT and application thereof | |
CN108795944A (en) | Cotton long-chain non-coding RNA-lnc973 and its application in plant salt endurance | |
CN105440116A (en) | Eggplant cryptochrome gene SmCRY2 and application thereof | |
CN105087508B (en) | Eggplant flavanone 3-hydroxylase SmF3H and its gene and application | |
CN113584035B (en) | Application of microRNA257 gene in regulation and control of secondary growth of poplar | |
CN105440115A (en) | Eggplant SmHY5 protein and coding gene thereof | |
CN108715852A (en) | A kind of Fruit Ripening of Tomato gene Sl0658 and its application | |
CN118562855A (en) | Application of Kale BoabHLH137 Gene in Regulating Plant Growth and Development and Carotenoid Content | |
CN111893132A (en) | A method for improving plant PAL enzyme activity and phenylpropane synthesis pathway activity | |
CN117866976A (en) | Application of Rice OsOGG1 Gene in Regulating Rice Resistance to Rice Blast | |
CN116240225A (en) | Series tobacco NtHQT gene and application thereof | |
CN102718853B (en) | Upland cotton GhLFY protein and coding gene and application thereof | |
CN116751810A (en) | Application of GmNAC121 gene in regulation and control of salt tolerance of soybeans | |
CN115807003B (en) | NtERF4 gene and its application in the regulation of total flavonoids and chlorogenic acid synthesis | |
CN116179562B (en) | Application of PavKLUH gene and its transcription factor PavRAV2 in regulating sweet cherry fruit size | |
CN118979048B (en) | Bupleurum bHLH transcription factor BcbHLH gene and application thereof | |
CN117721127A (en) | AtrBGAL2, the regulatory gene for peel dehiscence of Trichosanthes trifoliata and its encoded protein, primer pairs and applications | |
CN120041496A (en) | Application of BrFLD gene in regulating plant bolting and flowering | |
CN118530324A (en) | Application of BsMYB transcription factors in anthocyanin synthesis regulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |